glucose, (beta-d)-isomer has been researched along with Hyperprolactinemia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fan, H; Hou, L; Huang, X; Li, Y; Ren, L; Wang, C | 1 |
| Batey, R; La, L; Li, Y; Wang, C; Wang, L; Wei, Y | 1 |
2 other study(ies) available for glucose, (beta-d)-isomer and Hyperprolactinemia
| Article | Year |
|---|---|
Paeoniflorin ameliorates antipsychotic-induced hyperprolactinemia in rats by attenuating impairment of the dopamine D2 receptor and TGF-β1 signaling pathways in the hypothalamus and pituitary.
Topics: Animals; Antipsychotic Agents; Biomarkers; Cell Line, Tumor; Disease Models, Animal; Female; Glucosides; Hyperprolactinemia; Hypothalamus; Monoterpenes; Olanzapine; Pituitary Gland; Prolactin; Rats, Sprague-Dawley; Receptors, Dopamine D2; Signal Transduction; Transforming Growth Factor beta1 | 2020 |
Paeoniflorin and liquiritin, two major constituents in Chinese herbal formulas used to treat hyperprolactinemia-associated disorders, inhibits prolactin secretion in prolactinoma cells by different mechanisms.
Topics: Animals; Cell Line, Tumor; Drugs, Chinese Herbal; Female; Flavanones; Glucosides; Hyperprolactinemia; Metoclopramide; Monoterpenes; Pituitary Neoplasms; Prolactin; Prolactinoma; Rats, Sprague-Dawley | 2017 |